the

Onboarding holds the secret to closing the ‘revolving door’ of hiring in US manufacturing, Talogy research finds.

PITTSBURGH, March 24, 2026 /PRNewswire/ -- As US industrial sectors grapple with persistent labor shortages and high turnover, new research from Talogy,…

2 months ago

Rain Expands Visa Membership Into Asia-Pacific, Advancing the Reach of Its Global Stablecoin Payment Infrastructure

Rain's expanded issuing footprint enables global consumer and corporate credit card programs across some of the world's most digitally active…

2 months ago

Agero Receives Frost & Sullivan’s 2025 North American Digitalized Roadside Assistance Services Company of the Year Recognition for Market Leadership Excellence

The company is honored for redefining industrial performance through GenAI copilots, automation, and innovation that deliver measurable returns by improving…

2 months ago

Littlebird Raises $11 Million to Launch the Only AI That Already Knows What You’re Working On

The seed round, led by Lotus Studio, will scale the AI assistant built on a simple insight: context shouldn't be…

2 months ago

The 47% premium: How culture predicts market value in the AI era — Findings from Culture Amp

New Culture Amp research tracking 1,800 companies reveals a discrete measurable state of Peak Performance associated with a 36% share…

2 months ago

NYSE Content Update: The Hill & Valley Forum Convenes Leaders in Washington

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 24, 2026 /PRNewswire/ -- The New York…

2 months ago

Zocdoc Launches The AI-Informed Patient Report, Revealing How Patient Use of AI Is Reshaping the Patient-Provider Relationship

New findings highlight rising—yet hidden—patient use of AI and surprisingly optimistic providers, pointing to an emerging "triangle of care"NEW YORK,…

2 months ago

Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease…

2 months ago

Idorsia announces the nomination of three candidates for election to the Board of Directors

Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting…

2 months ago

Press Release: Sanofi and Regenerons Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…

2 months ago